Is influencer marketing the future of brand communication? Know how micro-influencers, authenticity, and blockchain ...
Influencer marketing is booming, but the largely unregulated industry is rife with fraud, discrimination, and just plain sketchy deals.
Are you a print subscriber? Activate your account. By Erika Wheless - 1 hour 58 min ago By Berkeley Bethune - 2 hours 33 min ago By Tim Nudd - 2 hours 35 min ago By Jack Neff - 2 hours 43 min ago 5 ...
From ASCI cracking down on influencers to SEBI calling out unregulated finfluencers packaging market opinions as “education, ...
The way consumers shop today looks nothing like it did a decade ago. Gone are the days when a flashy TV commercial or a celebrity endorsement could drive meaningful sales. Now, purchasing decisions ...
With India's influencer marketing growing in investment, impact, and ROI expectations, it has started showing its impact on consumer buying decisions. According to Kantar's latest norm-based research ...
Scroll through a TikTok feed, and you’ll eventually come across someone—usually incredibly photogenic, with perfect teeth and flawless skin—extolling the virtues of some product or another, or a ...
In a move that's sending ripples through the advertising world, Publicis Groupe has announced its acquisition of Influential, a leading AI-powered influencer marketing platform, in a deal reportedly ...
Since 2022, Collabstr's annual report, which spotlights the trends and insights shaping the influencer marketing scene, has become a go-to resource for brands and creators alike. Backed by first-party ...
The Advertising Standards Council of India (ASCI) has introduced an important update to its Influencer Advertising Guidelines, marked by the release of Addendum 2 specifically targeting health and ...
It’s an influencer world; we’re just living (and advertising) in it. Content creators have become a powerful force in the social media landscape, yet many advertisers are only just beginning to figure ...
In June, the Food and Drug Administration issued a warning letter about advertisements for the drug Recorlev for Cushing’s syndrome — its first in more than a year about webpages that make “false or ...